Accessibility navigation


Use of cannabinoids in the treatment of degenerative skeletal muscle disease

GW PHARMA LTD (2016) Use of cannabinoids in the treatment of degenerative skeletal muscle disease. WO2016059411.

[img]
Preview
Text (Patent publication document) - Published Version
· Please see our End User Agreement before downloading.

1MB

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Official URL: https://worldwide.espacenet.com/publicationDetails...

Abstract/Summary

The present invention relates to the use of canninoids in the treatment of egenerative skeletal muscle disease. In particular the skeletal muscle disease is Duchenne muscular dystrophy

Item Type:Patent
Divisions:Faculty of Life Sciences > School of Biological Sciences > Biomedical Sciences
ID Code:77217

Downloads

Downloads per month over past year

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation